Skip to content
This search input has a predictive search function. When 3 letters or more are entered, a number of predictive results appear in a dropdown. Use arrow keys to navigate and use the enter key to go to the page highlighted.
    RENEW JOIN
    Dashboard

    Emerging Topics in Psychiatry

    APA presents the Emerging Topics Webinar Series—learning opportunities analyzing the critical challenges faced in the profession and offering practical solutions from subject matter experts.

    New APA learning opportunities dedicated to keeping members up-to-date on important topics and the latest trends and information impacting the profession. Interact with your peers and subject matter experts. Topics are diverse, covering clinical practice updates, emerging psychedelic use, burnout and physician well-being, new legislation impacting your practice and patients, innovative technology and more.

    Upcoming Webinar

    The Frontier of Reproductive Psychiatry: New Treatments, New Tests, New Hope

    •  Tuesday, May 21
    •  3:00 – 4:30 p.m. ET
    •  1.5 AMA PRA Category 1 Credits™ **
    •  Jennifer L. Payne, M.D., Professor and Vice Chair of Research, Department of Psychiatry and Neurobehavioral Sciences, University of Virginia

    Reproductive Depressions are depressive episodes that are triggered by time of reproductive hormonal change in women, which may have a more homogeneous biological basis. Exciting research has recently led to two new medications for the treatment of Postpartum Depression with unique mechanisms of action as GABA Receptor positive allosteric modulators. Over a decade of research has also led to the development of a blood test for Postpartum Depression that is predictive with 80% accuracy based on epigenetic biomarkers. Both of these advancements are leading to alterations in the treatment approach to managing and potentially preventing postpartum depression.

    Learning Objectives

    • Define the terms "reproductive depression" and "epigenetics"
    • Analyze the primary mechanism of action of brexanolone and zuranolone, illustrating their respective roles in treating postpartum depression
    • Evaluate the impact of the new GAPA positive allosteric modulator drugs on the treatment strategy for postpartum depression
    • Discuss how identification of women at elevated risk for postpartum depression in the third trimester alters the treatment approach for postpartum depression

    Register Here

    Previous Webinars

    Watch the following webinars on demand in the APA Learning Center:

    For past emerging topics webinars and other educational content, visit the APA Learning Center at education.psychiatry.org.

    Other past topics include:

    • What Happens When the Public Health Emergency Ends? Telepsychiatry and Hybrid Practice Post-PHE
    • Evaluation, Management, Coding, and Documentation – What All Psychiatrists in Clinical Practice Need to Know
    • Facing the Hard Truths About Our Climate Disaster– Psychiatry's Role in Preparing society to accept a necessary shift in the Cultural Paradigm
    • The Covid-19 Pandemic and the Child Mental Health Crisis: What We Can Do Now
    • Heat Waves and Wildfires for the Practicing Psychiatrist: What you need to know to protect your patients and community
    • Denial: Nuclear Trauma and the Cold War Psychiatry in Hiroshima
    • Psychedelics as Therapeutics for Substance Use Disorders

    Accreditation

    **The American Psychiatric Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    The APA designates this enduring CME activity for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Medical leadership for mind, brain and body.

    Join Today